Finance

Lists
OBIMF:OTCMKTS
Ondine Biomedical Inc
0,22 USD
0,00%
(0,00) 1D
22-сен., 11:38:47 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OBIMF...
Mkt. cap
54,79 млн
Avg. vol.
167,00
Volume
0,00
52-wk high
0,25 USD
52-wk low
0,17 USD
Shares outstanding
561,22 млн
No. of employees
43
Mkt. cap
54,79 млн
Avg. vol.
167,00
Volume
0,00
52-wk high
0,25 USD
52-wk low
0,17 USD
Shares outstanding
561,22 млн
No. of employees
43
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
29 мүнөт мурун
FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE) in New York City
Opening Bell Daily
Opening Bell Daily
·
28 мүнөт мурун
Stock Market Outlook: Stock pickers are lagging the index
About Ondine Biomedical Inc
CEO-
Employees43
Founded1996
HeadquartersВанкувер, Бритиш Колумбия, Канада
SectorMedical device
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
816,50 миң
816,50 миң
622,50 миң
622,50 миң
Cost of goods sold
339,00 миң
339,00 миң
217,00 миң
217,00 миң
Cost of revenue
339,00 миң
339,00 миң
217,00 миң
217,00 миң
Research and development expenses
6,63 млн
6,63 млн
5,74 млн
5,74 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,45 млн
2,45 млн
2,50 млн
2,50 млн
Operating expense
9,20 млн
9,20 млн
8,36 млн
8,36 млн
Total operating expenses
9,54 млн
9,54 млн
8,58 млн
8,58 млн
Operating income
-8,72 млн
-8,72 млн
-7,96 млн
-7,96 млн
Other non operating income
26,50 миң
26,50 миң
-
-
EBT including unusual items
-8,48 млн
-8,48 млн
-8,08 млн
-8,08 млн
EBT excluding unusual items
-8,48 млн
-8,48 млн
-8,08 млн
-8,08 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,48 млн
-8,48 млн
-8,08 млн
-8,08 млн
Net profit margin
-1 038,46%
-1 038,46%
-1 297,91%
-1 297,91%
Earnings per share
-
-
-
-
Interest and investment income
90,00 миң
90,00 миң
28,00 миң
28,00 миң
Interest expense
-9,00 миң
-9,00 миң
-6,00 миң
-6,00 миң
Net interest expenses
81,00 миң
81,00 миң
22,00 миң
22,00 миң
Depreciation and amortization charges
120,00 миң
120,00 миң
126,00 миң
126,00 миң
EBITDA
-8,63 млн
-8,66 млн
-7,89 млн
-7,89 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору